Abstract:TGF-β and related growth factors activate a broad range of cellular responses and play key roles in the pathogenesis of many diseases especially cancer, fibrotic diseases, autoimmune diseases, and parasitic diseases. The activity of the TGF-β-initiated signaling pathway is tightly controlled, for example, through regulation of the key downstream SMAD tumor suppressors. In response to TGF-β, SMADs are phosphorylated, which triggers a series of downstream signaling and gene transcriptional events in the nucleus. To maintain proper levels of activated SMADs, activated SMADs in the nucleus are normally dephosphorylated by nuclear phosphatase PPM1A and then transported back into the cytoplasm. However, it remains elusive how dephosphorylated SMADs are exported out of the nucleus to ensure the completion of the SMAD signaling termination. Objective: To discover and characterize the underlying pathway that completes the step of SMAD signaling termination. Methods: A combinatorial approach using biochemical, cell biological, and developmental methods was used in this study. Cells were manipulated with expression plasmids for various SMADs, PPM1A, and potential nuclear exporter RanBP3. Xenopus embryos were manipulated using standard protocols. The level of phosphorylated SMADs was performed by western blotting. Nuclear export of SMADs was examined by immunofluorescence microscopy, cell lysate fractionation and a novel reporter assay. Protein-protein interaction of SMADs and RanBP3 was assessed by biochemical assays (e.g. IP-Western) or fluorescence assays. Results: We determined the essential function of RanBP3 in selective nuclear export of SMAD2/3 in the TGF-β pathway. RanBP3 directly recognized dephosphorylated SMAD2/3, which results from the activity of nuclear SMAD phosphatase PPM1A; PPM1A enhanced the physical interaction between RanBP3 and SMAD2/3. We clearly demonstrated that RanBP3 mediated nuclear export of SMAD2/3 in a small G protein Ran-dependent manner. Consequently, increased expression of RanBP3 inhibited TGF-β signaling in mammalian cells and Xenopus embryos, and depletion of RanBP3 expression or dominant negative inhibition of RanBP3 enhanced TGF-β-induced anti-proliferative and transcriptional responses. Finally, we have found that RanBP3 itself was phosphorylated in response to mitogenic growth signals and this phosphorylation could fine-tune the function of RanBP3 in exporting SMADs. Conclusion: We have defined a key role for RanBP3 in selectively mediating SMAD nuclear export and terminating TGF-β signaling. Thus, our finding should provide insights into the mechanisms of TGF-β anti-cancer actions. Knowledge gained from these studies will be used to design novel therapeutic strategies for prevention and treatment of human cancer.

Destabilization of Ran C-terminus promotes GTP loading and occurs in multiple Ran cancer mutations

GEF-independent Ran Activation Shifts a Fraction of the Protein to the Cytoplasm and Promotes Cell Proliferation.

Ran GTPase: A Key Player in Tumor Progression and Metastasis

Ran GTPase and Its Importance in Cellular Signaling and Malignant Phenotype

Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex

Coupled Actions of PPM1A and RanBP3 Terminate TGFβ/SMAD Tumor Suppressor Functions

Targeting of RCC1 to chromosomes is required for proper mitotic spindle assembly in human cells.

Epigenetic Silencing of a Ca2+-regulated Ras GTPase-activating Protein RASAL Defines a New Mechanism of Ras Activation in Human Cancers

The Multifaceted Roles of RCC1 in Tumorigenesis

Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4.

GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (Hvr)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site*

Conformational landscape alternations promote oncogenic activities of Ras-related C3 botulinum toxin substrate 1 as revealed by NMR

Ran GTPase: a master regulator of nuclear structure and function during the eukaryotic cell division cycle?

Distinct RanBP1 nuclear export and cargo dissociation mechanisms between fungi and animals

Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion

Rac1 Activation Controls Nuclear Localization of β-catenin during Canonical Wnt Signaling

Spatial and temporal coordination of mitosis by Ran GTPase

High Ran Level is Correlated with Poor Prognosis in Patients with Colorectal Cancer

Role of Ran GTPase in Cell Cycle Regulation

Ran Gtpase Protein Promotes Human Pancreatic Cancer Proliferation by Deregulating the Expression of Survivin and Cell Cycle Proteins